Clinical Trials Browser

Phase 1/2 × Melanoma × Histone Deacetylase Inhibitors × Clear all

NCT02836548 2025-07-10

HDAC Inhibitor Vorinostat in Resistant BRAF V600 Mutated Advanced Melanoma

Phase 1/2 Completed

Melanoma, Skin Neoplasms